US Patent 8926976 Modulators
Patent 8926976 was granted and assigned to XOMA on January, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+80 characters)
Article
Patent abstract
Antibodies that modulate insulin receptor signaling are provided.
Edits on 19 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
John Corbin1
Mark Leslie White1
Susan R. Watson1
Vinay Bhaskar1
Edits on 28 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08926976 Modulators US Patent 8926976 Modulators
Infobox
Patent Number
08926976
Patent Number
8926976
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 28 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08926976 Modulators
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08926976
Date of patent
January 6, 2015
Patent application number
12890598
Date Filed
September 24, 2010
Patent primary examiner
Find more entities like US Patent 8926976 Modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Content Issue